Memphasys Ltd (MEM) - Product Pipeline Analysis, 2018 Update
- GDME2283PD
- Pages: 25
- October 2018
- Total Views:1158
- Region : Asia
- GlobalData
- Equity Research Report

Details
Summary
Memphasys Ltd (Memphasys), formerly Nusep Holdings Ltd, is a bio-separations company that develops and commercializes membrane technology solutions. The company develops felix, a non-DNA damaging lab instrument for sperm separation that separates sperm from semen sample using electrophoresis and specialist membranes for the use in fertility treatments, including IVF for humans, artificial reproductive techniques for animals; and hydrogel membranes. It serves therapeutic plasma, IVF clinical, and research consumables markets. Memphasys also develops polymer membrane separation technology using polyacrylamide hydrogel membranes with electrophoresis. The company has operations in Australia, Singapore and the US. Memphasys is headquartered in Sydney, New South Wales, Australia.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Memphasys Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table Of Content
Scope
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Memphasys Ltd Company Overview 4
Memphasys Ltd Company Snapshot 4
Memphasys Ltd Pipeline Products and Ongoing Clinical Trials Overview 4
Memphasys Ltd-Pipeline Analysis Overview 6
Memphasys Ltd-Key Facts 6
Memphasys Ltd-Major Products and Services 7
Memphasys Ltd Pipeline Products by Development Stage 8
Memphasys Ltd Pipeline Products Overview 10
Felix 10
Felix Product Overview 10
Second Generation Clinical SpermSep Device 11
Second Generation Clinical SpermSep Device Product Overview 11
SpermSep200 12
SpermSep200 Product Overview 12
Memphasys Ltd-Key Competitors 13
Memphasys Ltd-Key Employees 14
Memphasys Ltd-Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Memphasys Ltd, Recent Developments 16
Jul 19, 2018: Attendance at ESHRE Conference in Spain generates interest from selected, pre-eminent IVF clinics to conduct in-vitro studies with Felix device to demonstrate sperm separation efficacy 16
Jun 07, 2018: Memphasys Appoints Marjan Mikel as Non-Executive Director 16
May 03, 2018: Felix Device Development On-Track 16
Jun 29, 2017: Memphasys: Update On Spermsep Development 17
May 18, 2017: Memphasys Provides Update On Next Stage Of SPERMSEP Development 17
Aug 10, 2015: Start Of In-Vitro Clinical Trial At Monash IVF 18
Nov 29, 2013: NuSep Board Changes 19
Oct 29, 2013: NuSep Announces Board Changes 19
Sep 06, 2013: NuSep Presents at Bioplasma Conference 20
Aug 30, 2013: NuSep announces 30 June 2013 Full Year Results 20
Appendix 22
Methodology 22
About GlobalData 25
Contact Us 25
Disclaimer 25
List Of Figure
List of Figures
Memphasys Ltd Pipeline Products by Equipment Type 5
Memphasys Ltd Pipeline Products by Development Stage 8
List Of Table
List of Tables
Memphasys Ltd Pipeline Products and Ongoing Clinical Trials Overview 4
Memphasys Ltd Pipeline Products by Equipment Type 5
Memphasys Ltd Pipeline Products by Indication 5
Memphasys Ltd, Key Facts 6
Memphasys Ltd, Major Products and Services 7
Memphasys Ltd Number of Pipeline Products by Development Stage 8
Memphasys Ltd Pipeline Products Summary by Development Stage 9
Felix-Product Status 10
Felix-Product Description 10
Second Generation Clinical SpermSep Device-Product Status 11
Second Generation Clinical SpermSep Device-Product Description 11
SpermSep200-Product Status 12
SpermSep200-Product Description 12
Memphasys Ltd, Key Employees 14
Glossary 24
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Products
Memphasys Ltd, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies
Companies
Factor Therapeutics Ltd
Regeneus Ltd
LBT Innovations Limited
Company Profile
Company Profile Title
Summary
Memphasys Ltd (Memphasys), formerly Nusep Holdings Ltd, is a bio-separations company that develops and commercializes membrane technology solutions. The company develops felix, a non-DNA damaging lab instrument for sperm separation that separates sperm from semen sample using electrophoresis and specialist membranes for the use in fertility treatments, including IVF for humans, artificial reproductive techniques for animals; and hydrogel membranes. It serves therapeutic plasma, IVF clinical, and research consumables markets. Memphasys also develops polymer membrane separation technology using polyacrylamide hydrogel membranes with electrophoresis. The company has operations in Australia, Singapore and the US. Memphasys is headquartered in Sydney, New South Wales, Australia.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Memphasys Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Scope
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Memphasys Ltd Company Overview 4
Memphasys Ltd Company Snapshot 4
Memphasys Ltd Pipeline Products and Ongoing Clinical Trials Overview 4
Memphasys Ltd-Pipeline Analysis Overview 6
Memphasys Ltd-Key Facts 6
Memphasys Ltd-Major Products and Services 7
Memphasys Ltd Pipeline Products by Development Stage 8
Memphasys Ltd Pipeline Products Overview 10
Felix 10
Felix Product Overview 10
Second Generation Clinical SpermSep Device 11
Second Generation Clinical SpermSep Device Product Overview 11
SpermSep200 12
SpermSep200 Product Overview 12
Memphasys Ltd-Key Competitors 13
Memphasys Ltd-Key Employees 14
Memphasys Ltd-Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Memphasys Ltd, Recent Developments 16
Jul 19, 2018: Attendance at ESHRE Conference in Spain generates interest from selected, pre-eminent IVF clinics to conduct in-vitro studies with Felix device to demonstrate sperm separation efficacy 16
Jun 07, 2018: Memphasys Appoints Marjan Mikel as Non-Executive Director 16
May 03, 2018: Felix Device Development On-Track 16
Jun 29, 2017: Memphasys: Update On Spermsep Development 17
May 18, 2017: Memphasys Provides Update On Next Stage Of SPERMSEP Development 17
Aug 10, 2015: Start Of In-Vitro Clinical Trial At Monash IVF 18
Nov 29, 2013: NuSep Board Changes 19
Oct 29, 2013: NuSep Announces Board Changes 19
Sep 06, 2013: NuSep Presents at Bioplasma Conference 20
Aug 30, 2013: NuSep announces 30 June 2013 Full Year Results 20
Appendix 22
Methodology 22
About GlobalData 25
Contact Us 25
Disclaimer 25
List Of Figure
List of Figures
Memphasys Ltd Pipeline Products by Equipment Type 5
Memphasys Ltd Pipeline Products by Development Stage 8
List Of Table
List of Tables
Memphasys Ltd Pipeline Products and Ongoing Clinical Trials Overview 4
Memphasys Ltd Pipeline Products by Equipment Type 5
Memphasys Ltd Pipeline Products by Indication 5
Memphasys Ltd, Key Facts 6
Memphasys Ltd, Major Products and Services 7
Memphasys Ltd Number of Pipeline Products by Development Stage 8
Memphasys Ltd Pipeline Products Summary by Development Stage 9
Felix-Product Status 10
Felix-Product Description 10
Second Generation Clinical SpermSep Device-Product Status 11
Second Generation Clinical SpermSep Device-Product Description 11
SpermSep200-Product Status 12
SpermSep200-Product Description 12
Memphasys Ltd, Key Employees 14
Glossary 24
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products
Memphasys Ltd, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies
Companies
Factor Therapeutics Ltd
Regeneus Ltd
LBT Innovations Limited